471 related articles for article (PubMed ID: 16965192)
1. Clinical perspectives on atypical antipsychotics for treatment of agitation.
Caine ED
J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
[TBL] [Abstract][Full Text] [Related]
2. A review of agitation in mental illness: treatment guidelines and current therapies.
Marder SR
J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
Brook S
J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
[TBL] [Abstract][Full Text] [Related]
4. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Kohen I; Preval H; Southard R; Francis A
Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
[TBL] [Abstract][Full Text] [Related]
5. Management of the agitated elderly patient in the nursing home: the role of the atypical antipsychotics.
Verma SD; Davidoff DA; Kambhampati KK
J Clin Psychiatry; 1998; 59 Suppl 19():50-5. PubMed ID: 9847052
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
[TBL] [Abstract][Full Text] [Related]
8. Treatment of agitation in bipolar disorder across the life cycle.
Alderfer BS; Allen MH
J Clin Psychiatry; 2003; 64 Suppl 4():3-9. PubMed ID: 12672259
[TBL] [Abstract][Full Text] [Related]
9. A review of agitation in mental illness: burden of illness and underlying pathology.
Sachs GS
J Clin Psychiatry; 2006; 67 Suppl 10():5-12. PubMed ID: 16965190
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
Lawlor BA
J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotic medications in the psychiatric emergency service.
Currier GW
J Clin Psychiatry; 2000; 61 Suppl 14():21-6. PubMed ID: 11154013
[TBL] [Abstract][Full Text] [Related]
12. The Expert Consensus Guideline Series. Treatment of behavioral emergencies.
Allen MH; Currier GW; Hughes DH; Reyes-Harde M; Docherty JP;
Postgrad Med; 2001 May; (Spec No):1-88; quiz 89-90. PubMed ID: 11500996
[TBL] [Abstract][Full Text] [Related]
13. [New formulations of olanzapine in the treatment of acute agitation].
Bartkó G
Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
[TBL] [Abstract][Full Text] [Related]
14. Management of agitation in the acute psychotic patient--efficacy without excessive sedation.
Cañas F
Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S108-14. PubMed ID: 17336765
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute agitation in psychotic disorders.
Mohr P; Pecenák J; Svestka J; Swingler D; Treuer T
Neuro Endocrinol Lett; 2005 Aug; 26(4):327-35. PubMed ID: 16136016
[TBL] [Abstract][Full Text] [Related]
16. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting.
Correll CU; Yu X; Xiang Y; Kane JM; Masand P
Ann Clin Psychiatry; 2017 May; 29(2):92-107. PubMed ID: 28463343
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics for acute agitation. New intramuscular options offer advantages.
Citrome L
Postgrad Med; 2002 Dec; 112(6):85-8, 94-6. PubMed ID: 12510449
[TBL] [Abstract][Full Text] [Related]
18. The emergency treatment of depression complicated by psychosis or agitation.
Glick RL; Ghaemi SN
J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
[TBL] [Abstract][Full Text] [Related]
19. Injectable atypical antipsychotics for agitation in borderline personality disorder.
Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
[TBL] [Abstract][Full Text] [Related]
20. Droperidol: efficacy and side effects in psychiatric emergencies.
Chambers RA; Druss BG
J Clin Psychiatry; 1999 Oct; 60(10):664-7. PubMed ID: 10549682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
